The Clinical Innovation Platform (CLIP), powered by National Bank, is pleased to announce PL Signals as our new member.

PL Signals is a start-up based in Quebec that is dedicated to developing anti-fibrotic drugs for the treatment of lung and skin fibrosis. They are also focused on creating anti-cancer drugs that inhibit oncogenic signaling pathways.

With CLIP support, PL Signals will identify partners for a joint venture focused on developing drug formulations for nasal or topical delivery. In addition, they will explore opportunities for out-licensing their technology.